A third drug, pretomanid, received emergency authorization from the FDA for specific use within a regimen against highly drug ...

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...

In a special report published in August 2024, the WHO added the three noninferior regimens from the endTB trial to the list of treatment options for rifampin-resistant and multidrug-resistant TB ...

A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of drug-resistant tuberculosis (TB), researchers reported this week in the New ...

Tuberculosis remains one of the deadliest infectious diseases worldwide, with drug-resistant strains posing a significant ...

New options make TB treatment faster, safer, and more accessible. A major breakthrough in tuberculosis treatment has emerged: ...

Tuberculosis remains one of the top infectious disease killers worldwide , a challenge amplified by drug-resistant forms of the disease. Now, in a ...

A tuberculosis (TB) patient is said to be multidrug-resistant when the bacteria strain causing the infection has become ...

Multidrug-resistance is a significant challenge in eliminating the bacterial disease, as the complication increases treatment durations, which further risks the spread of the infection.

Studies have found that children and teenagers treated for multidrug-resistant tuberculosis, including those in India, are under-represented in case numbers. Read on to know more.

Kansas is experiencing its most significant tuberculosis outbreak, with 67 active and 79 latent cases reported in Wyandotte ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In the ...